1Bertone P, Snyder M. Advances in functional protein microarray technology [ J ]. FEBS J, 2005,272 : 5400 - 5411.
2Lai IR, Lee WJ, Huang MT, et al. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence [ J ]. Hepatogastroenterology, 2002, 49(46) :1157 - 1160.
3Ni XG, Bai XF, Mao YL, et al. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer[J]. Eur J Surg Oncol, 2005,31(2) :164 -169.
6Mihmanli M, Dilege E, Demir U, et al. The use of tumor markers as predictors of prognosis in gastric cancer [ J ]. Hepatogastroenterology, 2004,51(59) :1544 -1547.
二级参考文献9
1Banf G,Bravi S,Ardemagm A,et al.CA199,CA242 and CEA in the diagnosis and follow-up of pancreatic cancer[J].Int J Biol Markers,1996,11(2):77-81.
2Paweletzcp C P,Cillespie J W,Ornstein D K,et al.Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip[J].Deve Res,2000,49(1):34.
3Eggeling F,Davies H,Lomas L,et al.Tissue-specific microdissection couple with proteinchip array technologies:applications in cancer research[J].Biotechniques,2000,29(5):1066-1070.
4Chen J T,Yu K C,Chang M,et al.Use of PAPNET testing to revaluate preceeding negative cervical smears of women with high grade squamous intraepithelial lesion and caicinoma[J].Acta Cytil,1998,42:466.
5Kobayashi H,Tamura M,Satoh T.Clinical evaluation of new cancer-assiciated antigen CA125 in epithelial ovarian cancers:comparison with CA125[J].Clin Biochem,1993,26(3):213-219.
6叶靖.C12多种肿瘤标志物蛋白芯片的临床应用[J].中国家庭医学研究,2004,4:1-2.
7Gaspar MJ,Arribas I,Coca MC,et al.Prognostic value of carcinoembryonic antigen,CA19-9 and CA72-4 in gastric carcinoma.Tumor Bio1,2001,22:318-322.
